294 related articles for article (PubMed ID: 20467343)
21. Magnetic resonance study of the pancreatic duct.
Calvo MM; Calderón A; Heras I; Durán M; Orive V; Cabriada J; Astigarraga E
Rev Esp Enferm Dig; 1999 Apr; 91(4):287-96. PubMed ID: 10348928
[TBL] [Abstract][Full Text] [Related]
22. MRCP and MRI findings in 9 patients with autoimmune pancreatitis.
Kamisawa T; Chen PY; Tu Y; Nakajima H; Egawa N; Tsuruta K; Okamoto A; Kamata N
World J Gastroenterol; 2006 May; 12(18):2919-22. PubMed ID: 16718819
[TBL] [Abstract][Full Text] [Related]
23. ERCP and MRCP--when and why.
Albert JG; Riemann JF
Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):399-419. PubMed ID: 12079266
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune pancreatitis.
Krasinskas AM; Raina A; Khalid A; Tublin M; Yadav D
Gastroenterol Clin North Am; 2007 Jun; 36(2):239-57, vii. PubMed ID: 17533077
[TBL] [Abstract][Full Text] [Related]
25. A new diagnostic endoscopic tool for autoimmune pancreatitis.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A
Gastrointest Endosc; 2008 Aug; 68(2):358-61. PubMed ID: 18513718
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance pancreatography.
Barish M; Soto J; Ferrucci J
Endoscopy; 1997 Aug; 29(6):487-95. PubMed ID: 9342566
[TBL] [Abstract][Full Text] [Related]
27. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP.
Carbognin G; Girardi V; Biasiutti C; Camera L; Manfredi R; Frulloni L; Hermans JJ; Mucelli RP
Radiol Med; 2009 Dec; 114(8):1214-31. PubMed ID: 19789959
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of magnetic resonance cholangiopancreatography in identifying pancreatic duct disruption.
Drake LM; Anis M; Lawrence C
J Clin Gastroenterol; 2012 Sep; 46(8):696-9. PubMed ID: 22565603
[TBL] [Abstract][Full Text] [Related]
30. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings.
Shin JU; Lee JK; Kim KM; Lee KH; Lee KT; Kim YK; Lim JH; Jang KT
Hepatogastroenterology; 2013; 60(125):1174-81. PubMed ID: 24298613
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic endoscopic retrograde cholangiopancreatography.
Schöfl R
Endoscopy; 2001 Feb; 33(2):147-57. PubMed ID: 11272217
[TBL] [Abstract][Full Text] [Related]
32. The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease.
Sahai AV; Devonshire D; Yeoh KG; Kay C; Feldman D; Willner I; Farber J; Patel R; Tamasky PR; Cunningham JT; Trus T; Hawes RH; Cotton PB
Am J Gastroenterol; 2001 Jul; 96(7):2074-80. PubMed ID: 11467634
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of endoscopic ultrasonography, magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography in patients suspected of pancreaticobiliary disease.
Ainsworth AP; Rafaelsen SR; Wamberg PA; Pless T; Durup J; Mortensen MB
Scand J Gastroenterol; 2004 Jun; 39(6):579-83. PubMed ID: 15223684
[TBL] [Abstract][Full Text] [Related]
34. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings.
Nishino T; Oyama H; Toki F; Shiratori K
J Gastroenterol; 2010 Sep; 45(9):988-96. PubMed ID: 20396913
[TBL] [Abstract][Full Text] [Related]
35. [Magnetic resonance cholangiopancreatography (MRCP) from a radiological and gastroenterological perspective].
Vogl TJ; Zeuzem S; Zangos S; Hammerstingl R
Dtsch Med Wochenschr; 2009 May; 134(19):1011-4. PubMed ID: 19401971
[TBL] [Abstract][Full Text] [Related]
36. The effect of prior sphincterotomy on the secretin-stimulated magnetic resonance cholangiopancreatography (s-MRCP).
Chopra A; Alkaade S; Balci NC; Burton F
Acad Radiol; 2009 Nov; 16(11):1381-5. PubMed ID: 19683944
[TBL] [Abstract][Full Text] [Related]
37. [MRI cholangiopancreatography in the pathology of the bile ducts and pancreas].
Taourel P; Calvet C; Lecesne R; Pradel JA; Drouillard J; Bruel JM
J Radiol; 1997 Sep; 78(9):615-21. PubMed ID: 9537179
[TBL] [Abstract][Full Text] [Related]
38. Comparison of endoscopic retrograde and magnetic resonance cholangiopancreatography in the surgical diagnosis of pancreatic diseases.
Yamaguchi K; Chijiwa K; Shimizu S; Yokohata K; Morisaki T; Tanaka M
Am J Surg; 1998 Mar; 175(3):203-8. PubMed ID: 9560120
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of MRCP and indications for ERCP.
Sakai Y; Tsuyuguchi T; Tsuchiya S; Sugiyama H; Miyakawa K; Ebara M; Saisho H; Yokosuka O
Hepatogastroenterology; 2007 Dec; 54(80):2212-5. PubMed ID: 18265635
[TBL] [Abstract][Full Text] [Related]
40. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings.
Alkaade S; Cem Balci N; Momtahen AJ; Burton F
J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
